Tc99m has a
6-hour half life, enabling nuclear medicine physicians to image patients about 3 hours
after injection, using readily available SPECT (single-photon emission computed
tomography…"nuclear CT") cameras. The short half-life of technetium,
coupled with the small molecular-weight fragment, allows for rapid clearance from the
blood and organs and early localization at tumor sites.